ELGX News and Press, Endologix Inc. From 11/03/18

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Yep, there is an election next week that's going to steal some headlines, but inves...

Endologix Inc. (ELGX) Q3 2018 Earnings Conference Call November 01, 2018 4:30 PM ET Executives John Onopchenko – Chief Executive Officer Vaseem Mahboob – Chief Financial Officer Matt Thompson – Chief Medical Officer Analysts Matthew Blackman – St...

Endologix (NASDAQ: ELGX ): Q3 GAAP EPS of -$0.12 beats by $0.18 . More news on: Endologix Inc, Earnings news and commentary, Healthcare stocks news, , Read more ...

Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the third quarter ended September 30, 2018. “While there is still significant work to be done, our third...

AAPL , ACIA , ACLS , AIRG , AIV , ALEX , AMH , ANET , AOSL , APPN , ARCB , ATGE , ATHN , ATR , ATRC , ATSG , BCOV , BFAM , BIO , BL , BLDR , BNFT , BRKR , BVX , CARB , CATM , CBPO , CBS , CC , CCRN , CECO , CERS , CHEF , CNMD , CNXN , CORT , CPS , CPSI ...

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will present at the following two investor conferences in November: Conference: Stephens NY Investment Conference Location: New York, NY Date: Tuesday, November ...

Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), developer and marketer of innovative treatments for aortic disorders, announced today the pricing of a registered underwritten public offering of its common stock for net proceeds of $20.0 million, bef...

AMD   -20%  on  Q3 earnings . More news on: Advanced Micro Devices, Inc., Align Technology, Inc., WPP Plc, Stocks on the move, Top stock market news, , Read more ...